ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Letter To The Editor: Prevention Research Requires Rigor And Collaboration.

June 20, 2003

SEER Program Expansion Through Cost-Sharing.

March 23, 2001

Plant-Based Diet Associated With Improved Survival

April 25, 2008

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show

July 30, 1999

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992